$0.57
Today
as of Sep 4, 16:46 ET
Last 30 days
Recent Press Releases & News
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
BBLG Efficiency Improves as Crucial Trials Advance
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances
Overview
52-week range
$0.54
$2.89
1% of range
Avg surprise (last 2)
-54.5%
Avg reaction (last 2)
-2.5%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.43 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $-0.43 | $-0.54 | +20.4% | -34.4% | -2.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.37 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-1.33 | $-0.58 | -129.3% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.32 | — | — | — | -2.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-14.21 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-4.02 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.31 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-4.90 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-5.21 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-55.20 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-808,106 | $-805,054 | — | $-715,274 | $-748,075 | $-1M | — | $-951,021 |
| Net income | $-773,702 | $-765,988 | — | $-666,737 | $-740,519 | $-1M | — | $-941,002 |
| EPS (diluted) | $-0.43 | $-0.43 | — | $-0.37 | $-1.33 | $-1.92 | — | $-14.21 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $5M | $5M | $6M | $7M | $3M | — | $4M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $4M | $5M | $6M | $6M | $7M | $3M | $4M | $4M |
| Total assets | $4M | $5M | $6M | $6M | $7M | $3M | $4M | $4M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $512,018 | $309,386 | $418,587 | $334,282 | $406,142 | $251,158 | $377,712 | $273,402 |
| Total equity | $4M | $5M | $5M | $6M | $7M | $3M | $3M | $4M |
Implied volatility — last 90 days
No IV snapshots yet for BBLG.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.